Diego Alignani
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 19
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 7
- Immune Response and Inflammation 5
- Immune cells in cancer 4
- Hematology 11
- Multiple Myeloma Research and Treatments 10
- Co-authors
- Belkys Maletto (5 shared papers)María C. Pistoresi‐Palencia (5 shared papers)Andrea S. Rópolo (3 shared papers)Ignacio Melero (3 shared papers)Sandra Hervás‐Stubbs (6 shared papers)Carlos Alfaro (2 shared papers)Pedro Berraondo (3 shared papers)Miguel F. Sanmamed (2 shared papers)
- Journals
- Blood (9 papers)Clinical Cancer Research (2 papers)The Journal of Immunology (2 papers)Immunology (1 paper)Journal of Leukocyte Biology (1 paper)
- Partner nations
- SpainArgentinaUnited Kingdom
In The Last Decade
Diego Alignani
27 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Immunology 670
- Oncology 453
- Hematology 172
- Physiology 39
- Immunology and Allergy 46
Countries citing papers authored by Diego Alignani
This map shows the geographic impact of Diego Alignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Alignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Alignani more than expected).
Fields of papers citing papers by Diego Alignani
This network shows the impact of papers produced by Diego Alignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Alignani. The network helps show where Diego Alignani may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Alignani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 316 | |
| 2 | 2019 | 148 | |
| 3 | 2006 | 121 | |
| 4 | 2017 | 107 | |
| 5 | 2010 | 65 | |
| 6 | 2005 | 57 | |
| 7 | 2019 | 48 | |
| 8 | 2016 | 40 | |
| 9 | 2012 | 36 | |
| 10 | 2020 | 28 | |
| 11 | 2005 | 27 | |
| 12 | 2008 | 24 | |
| 13 | 2014 | 22 | |
| 14 | 2019 | 20 | |
| 15 | 2021 | 16 | |
| 16 | 2016 | 13 | |
| 17 | 2016 | 10 | |
| 18 | 2015 | 8 | |
| 19 | 2011 | 7 | |
| 20 | 2016 | 7 |
About Diego Alignani
Diego Alignani is a scholar working on Immunology, Hematology, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (8 papers), Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers), Immune Response and Inflammation (5 papers), Immune cells in cancer (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Immunology (670 citations), Oncology (453 citations), Hematology (172 citations), Physiology (39 citations) and Immunology and Allergy (46 citations). Diego Alignani has collaborated with scholars based in Spain, Argentina and United Kingdom. Frequent co-authors include Belkys Maletto, María C. Pistoresi‐Palencia, Andrea S. Rópolo, Ignacio Melero, Sandra Hervás‐Stubbs, Carlos Alfaro, Pedro Berraondo, Miguel F. Sanmamed, Guiomar Pérez and Carmen Oñate. Their work appears in journals such as Blood, Clinical Cancer Research, The Journal of Immunology, Immunology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.